Diagnostic delay in PAH persists, linked to lower survival
09 Aug 2020
Despite increased community awareness, diagnostic delays persist among patients with pulmonary arterial hypertension (PAH), claims a recent study, noting that those who experience longer diagnostic interval are at higher risk of mortality.
Empagliflozin near to us: Insights from its use in Asians
09 Jul 2020;
In this fourth issue,
join us as we discover the unique biology Asians have with respect to diabetes.
Take a closer look at trials evaluating whether empagliflozin’s cardiovascular
and renal benefits – as analysed in Asians – are consistent with the overall
trial population, and how it addresses unmet needs.